UTI Asset Management Company Limited has submitted mandatory regulatory certificates under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The company filed these certificates through its registrar and share transfer agent, KFin Technologies Limited, as part of its ongoing compliance obligations.

Regulatory Filing Details

The company submitted the certificates under reference number UTI/AMC/CS/SE/2026-27/0651 dated April 6, 2026. The filing was made to both major stock exchanges where UTI AMC shares are listed:

SEBI Regulation 74(5) Compliance

KFin Technologies Limited, acting as the registrar and share transfer agent, issued certificates dated April 2, 2026, confirming compliance with SEBI Regulation 74(5). These certificates were submitted to both Central Depository Services (India) Limited (CDSL) and National Securities Depository Limited (NSDL).

Certificate Verification Process

The certificates confirm that details of securities dematerialized and rematerialized during Q4FY26 have been properly furnished to all stock exchanges where UTI AMC shares are listed. Rajitha Cholleti, Vice President at KFin Technologies Limited, signed the certificates on behalf of the registrar.

Corporate Governance Framework

Arvind Patkar, Company Secretary and Compliance Officer (Membership No. ACS 21577), signed the regulatory filing on behalf of UTI AMC. The submission demonstrates the company's adherence to SEBI's depositories regulations and maintains transparency in share transfer and dematerialization processes. This regulatory compliance ensures proper tracking and reporting of all securities transactions during the specified quarter.

UTI AMC has announced that its board of directors will convene on April 23, 2026, to review and approve the company's audited financial results for the fourth quarter and full financial year ending March 31, 2026. The meeting notification was issued on March 20, 2026, in accordance with regulatory compliance requirements.

Board Meeting Agenda

The upcoming board meeting will address several key corporate matters as outlined in the official communication:

Trading Window Closure

In compliance with insider trading regulations, the company has announced a trading window closure for designated persons and their immediate relatives. The trading restrictions will be effective from April 1, 2026, to April 25, 2026 (both days inclusive).

Regulatory Compliance

The board meeting intimation has been issued pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to inform stock exchanges about board meetings where financial results and dividend recommendations are to be considered.

The company has ensured compliance with Regulation 46 of the SEBI Listing Regulations by making this intimation available on its official website at www.utimf.com . Additionally, the company has confirmed compliance with relevant SEBI circulars by freezing the PAN of designated persons and updating the window closure dates with Central Depository Services (India) Limited.

Corporate Communication Details

The official communication was signed by Arvind Patkar, Company Secretary and Compliance Officer, who holds membership number ACS 21577. The intimation was digitally signed on March 20, 2026, and sent to both major stock exchanges where the company's shares are listed.

The notification was addressed to the National Stock Exchange of India Limited and BSE Limited, where UTI Asset Management Company Limited trades under the symbol UTIAMC. This formal communication ensures that all stakeholders, including investors and regulatory bodies, are informed about the scheduled board meeting and trading restrictions well in advance.